AAAAAA
Results: 26-37/37
Authors:
BROWN AE
SINGHARAJ P
WEBSTER HK
PIPITHKUL J
GORDON DM
BOSLEGO JW
KRINCHAI K
SUARCHAWARATANA P
WONGSRICHANALAI C
BALLOU WR
PERMPANICH B
KAIN KC
HOLLINGDALE MR
WITTES J
QUE JU
GROSS M
CRYZ SJ
SADOFF JC
Citation: Ae. Brown et al., SAFETY, IMMUNOGENICITY AND LIMITED EFFICACY STUDY OF A RECOMBINANT PLASMODIUM-FALCIPARUM CIRCUMSPOROZOITE VACCINE IN THAI SOLDIERS, Vaccine, 12(2), 1994, pp. 102-108
Authors:
EDELMAN R
TAYLOR DN
WASSERMAN SS
MCCLAIN JB
CROSS AS
SADOFF JC
QUE JU
CRYZ SJ
Citation: R. Edelman et al., PHASE-1 TRIAL OF A 24-VALENT KLEBSIELLA CAPSULAR POLYSACCHARIDE VACCINE AND AN 8-VALENT PSEUDOMONAS O-POLYSACCHARIDE CONJUGATE VACCINE ADMINISTERED SIMULTANEOUSLY, Vaccine, 12(14), 1994, pp. 1288-1294
Authors:
GLUCK R
MISCHLER R
FINKEL B
QUE JU
SCARPA B
CRYZ SJ
Citation: R. Gluck et al., IMMUNOGENICITY OF NEW VIROSOME INFLUENZA VACCINE IN ELDERLY PEOPLE, Lancet, 344(8916), 1994, pp. 160-163
Authors:
CROSS A
ARTENSTEIN A
QUE J
FREDEKING T
FURER E
SADOFF JC
CRYZ SJ
Citation: A. Cross et al., SAFETY AND IMMUNOGENICITY OF A POLYVALENT ESCHERICHIA-COLI VACCINE INHUMAN VOLUNTEERS, The Journal of infectious diseases, 170(4), 1994, pp. 834-840
Authors:
CRYZ SJ
WEDGWOOD J
LANG AB
RUEDEBERG A
QUE JU
FURER E
SCHAAD UB
Citation: Sj. Cryz et al., IMMUNIZATION OF NONCOLONIZED CYSTIC-FIBROSIS PATIENTS AGAINST PSEUDOMONAS-AERUGINOSA, The Journal of infectious diseases, 169(5), 1994, pp. 1159-1162
Authors:
POOVORAWAN Y
TIEAMBOONLERS A
CHUMDERMPADETSUK S
GLUCK R
CRYZ SJ
Citation: Y. Poovorawan et al., CONTROL OF A HEPATITIS A OUTBREAK BY ACTIVE IMMUNIZATION OF HIGH-RISKSUSCEPTIBLE SUBJECTS, The Journal of infectious diseases, 169(1), 1994, pp. 228-229
Authors:
JOHANSEN HK
ESPERSEN F
CRYZ SJ
HOUGEN HP
FOMSGAARD A
RYGAARD J
HOIBY N
Citation: Hk. Johansen et al., IMMUNIZATION WITH PSEUDOMONAS-AERUGINOSA VACCINES AND ADJUVANT CAN MODULATE THE TYPE OF INFLAMMATORY RESPONSE SUBSEQUENT TO INFECTION, Infection and immunity, 62(8), 1994, pp. 3146-3155
Authors:
BRAUNER A
CRYZ SJ
GRANSTROM M
HANSON HS
LOFSTRAND L
STRANDVIK B
WRETLIND B
Citation: A. Brauner et al., IMMUNOGLOBULIN-G ANTIBODIES TO PSEUDOMONAS-AERUGINOSA LIPOPOLYSACCHARIDES AND EXOTOXIN-A IN PATIENTS WITH CYSTIC-FIBROSIS OR BACTEREMIA, European journal of clinical microbiology & infectious diseases, 12(6), 1993, pp. 430-436
Authors:
LANG AB
FURER E
CRYZ SJ
Citation: Ab. Lang et al., FEASIBILITY OF PROPHYLAXIS AND THERAPY AGAINST GRAM-NEGATIVE INFECTIONS BY HUMAN MONOCLONAL-ANTIBODIES, FEMS immunology and medical microbiology, 7(1), 1993, pp. 9-13
Authors:
TACKET CO
LOSONSKY G
NATARO JP
CRYZ SJ
EDELMAN R
FASANO A
MICHALSKI J
KAPER JB
LEVINE MM
Citation: Co. Tacket et al., SAFETY AND IMMUNOGENICITY OF LIVE ORAL CHOLERA VACCINE CANDIDATE CVD 110, A DELTA-CTXA DELTA-ZOT DELTA-ACE DERIVATIVE OF EL-TOR OGAWA VIBRIO-CHOLERAE, The Journal of infectious diseases, 168(6), 1993, pp. 1536-1540
Authors:
SAXEN H
VUOPIOVARKILA J
LUK J
LINDBERG A
LANG A
DIPADOVA F
CRYZ SJ
MERTSOLA J
MCCRACKEN GH
HANSEN EJ
Citation: H. Saxen et al., DETECTION OF ENTEROBACTERIAL LIPOPOLYSACCHARIDES AND EXPERIMENTAL ENDOTOXEMIA BY MEANS OF AN IMMUNOLIMULUS ASSAY USING BOTH SEROTYPE-SPECIFIC AND CROSS-REACTIVE ANTIBODIES, The Journal of infectious diseases, 168(2), 1993, pp. 393-399
Authors:
LANG AB
CRYZ SJ
SCHURCH U
GANSS MT
BRUDERER U
Citation: Ab. Lang et al., IMMUNOTHERAPY WITH HUMAN MONOCLONAL-ANTIBODIES - FRAGMENT-A SPECIFICITY OF POLYCLONAL AND MONOCLONAL-ANTIBODIES IS CRUCIAL FOR FULL PROTECTION AGAINST TETANUS TOXIN, The Journal of immunology, 151(1), 1993, pp. 466-472